Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 3/20 | 0.89 |
| ▸ | CNR1 | P21554 | 1/20 | 0.49 |
| ▸ | CNR2 | P34972 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.45 |
| ▸ | OXER1 | Q8TDS5 | 4/20 | 0.45 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.45 |
| ▸ | PPARG | P37231 | 3/20 | 0.45 |
| ▸ | MAPT | P10636 | 3/20 | 0.45 |
| ▸ | RXRA | P19793 | 2/20 | 0.45 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.45 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.42 |
| ▸ | F7 | P08709 | 3/20 | 0.42 |
| ▸ | F3 | P13726 | 3/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | PPARD | Q03181 | 2/20 | 0.42 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4445473 | 1.00 | PPARA (0.89) | PPARACNR1CNR2ALDH1A1OXER1 | |
| SCHEMBL13674213 | 1.00 | PPARA (0.89) | PPARACNR1CNR2ALDH1A1OXER1 | |
| SCHEMBL2745181 | 0.94 | PPARA (1.00) | PPARACNR1CNR2ALDH1A1OXER1 | |
| SCHEMBL2745188 | 0.94 | PPARA (1.00) | PPARACNR1CNR2ALDH1A1OXER1 | |
| SCHEMBL6405870 | 0.92 | PPARA (0.96) | PPARACNR1CNR2ALDH1A1OXER1 | |
| SCHEMBL2744282 | 0.92 | PPARA (0.96) | PPARACNR1CNR2ALDH1A1OXER1 | |
| SCHEMBL5886676 | 0.92 | PPARA (0.96) | PPARACNR1CNR2ALDH1A1OXER1 | |
| SCHEMBL23698136 | 0.90 | PPARA (0.73) | PPARAALDH1A1OXER1CYP19A1PPARG | |
| SCHEMBL8586194 | 0.90 | PPARA (0.73) | PPARAALDH1A1OXER1CYP19A1PPARG | |
| SCHEMBL3272127 | 0.90 | PPARA (0.73) | PPARAALDH1A1OXER1CYP19A1PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1496042-B1 | E2, E4,Z8-Undecatrienoic acid and ester and carboxamide derivatives thereof, organoleptic uses thereof and processes for preparing same | INT FLAVORS & FRAGRANCES INC (US) | 2009-11-11 | — | — | EP | claimed |
| US-20050197387-A1 | E2,E4,Z8-undecatrienoic acid and ester and carboxamide derivatives thereof, organoleptic uses thereof and processes for preparing same | INTERNATIONAL FLAVORS & FRAGARANCES INC. | 2005-09-08 | — | — | US | claimed |
| US-20050010062-A1 | E2,E4,Z8-UNDECATRIENOIC ACID AND ESTER AND CARBOXAMIDE DERIVATIVES THEREOF, ORGANOLEPTIC USES THEREOF AND PROCESSES FOR PREPARING SAME | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2005-01-13 | — | — | US | claimed |
| EP-1496042-A2 | E2, E4,Z8-Undecatrienoic acid and ester and carboxamide derivatives thereof, organoleptic uses thereof and processes for preparing same | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2005-01-12 | — | — | EP | claimed |
| EP-2112135-B1 | E2, E4,Z8-undecatrienoic acid and ester and carboxamide derivatives thereof, organoleptic uses thereof and processes for preparing same | INT FLAVORS & FRAGRANCES INC (US) | 2013-06-19 | — | — | EP | disclosed |
| EP-1496042-B1 | E2, E4,Z8-Undecatrienoic acid and ester and carboxamide derivatives thereof, organoleptic uses thereof and processes for preparing same | INT FLAVORS & FRAGRANCES INC (US) | 2009-11-11 | — | — | EP | disclosed |
| EP-2112135-A2 | E2, E4,Z8-undecatrienoic acid and ester and carboxamide derivatives thereof, organoleptic uses thereof and processes for preparing same | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2009-10-28 | — | — | EP | disclosed |
| US-7141686-B2 | E2, E4, Z8-undecatrienoic acid and ester and carboxamide derivatives thereof, organoleptic uses thereof and processes for preparing same | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2006-11-28 | — | — | US | disclosed |
| US-7098350-B2 | E2,E4,Z8-undecatrienoic acid and ester and carboxamide derivatives thereof, organoleptic uses thereof and processes for preparing same | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2006-08-29 | — | — | US | disclosed |
| US-20050197387-A1 | E2,E4,Z8-undecatrienoic acid and ester and carboxamide derivatives thereof, organoleptic uses thereof and processes for preparing same | INTERNATIONAL FLAVORS & FRAGARANCES INC. | 2005-09-08 | — | — | US | disclosed |
| US-20050010062-A1 | E2,E4,Z8-UNDECATRIENOIC ACID AND ESTER AND CARBOXAMIDE DERIVATIVES THEREOF, ORGANOLEPTIC USES THEREOF AND PROCESSES FOR PREPARING SAME | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2005-01-13 | — | — | US | disclosed |
| EP-1496042-A2 | E2, E4,Z8-Undecatrienoic acid and ester and carboxamide derivatives thereof, organoleptic uses thereof and processes for preparing same | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2005-01-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050010062-A1 | E2,E4,Z8-UNDECATRIENOIC ACID AND ESTER AND CARBOXAMIDE DERIVATIVES THEREOF, ORGANOLEPTIC USES THEREOF AND PROCESSES FOR PREPARING SAME | ESRRA, TECR, TAS2R8 | PPARA 43/4885CNR1 55/4885CNR2 65/4885 |
| US-20050197387-A1 | E2,E4,Z8-undecatrienoic acid and ester and carboxamide derivatives thereof, organoleptic uses thereof and processes for preparing same | UBE4A, TAS2R8, CUTA | PPARA 12/4885CNR1 387/4885CNR2 155/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.